• CellPoint and Lonza Enter Strategic Collaboration contractpharma
    June 25, 2021
    CellPoint has signed an agreement with Lonza's Personalized Medicine Business Unit to employ Lonza's Cocoon Platform for clinical manufacturing of CellPoint's CAR-T cell therapies at the point-of-care, more rapidly and at lower cost.
PharmaSources Customer Service